Effect of Azithromycin injection on mycoplasma pneumoniae pneumonia in children
10.3760/cma.j.issn.1008-6315.2011.07.033
- VernacularTitle:希舒美针剂治疗儿童肺炎支原体肺炎疗效观察
- Author:
Mengjuan WANG
;
Chongshan LIU
;
Zheng WANG
;
Xueyan WANG
;
Yi ZHANG
- Publication Type:Journal Article
- Keywords:
Pneumonia;
Mycoplasma pneumonia;
Azithromycin;
Children
- From:
Clinical Medicine of China
2011;27(7):762-764
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect Azithromycin injection in the treatment of mycoplasma pneumoniae pneumonia ( MPP) in children. Methods Forty-four children of mycoplasma pneumoniae pneumonia were randomly divided into two groups, the Azithromycin group ( treat by Azithromycin, made by Pfizer) and the control group (treat by domestic Azithromycin) respectively. Improvement in symptoms and signs between the two groups were observed and compared. Results There were 25 cases in the Azithromycin group, of which,after a week, 17 cases cured,2 cases got better significantly and 6 cases got better. The effective ratio was 76. 00% ( 19/25 ). There were 19 cases in the control group, of which 5 cases cured, 9 cases got better significantly ,4 cases got better and 1 case no change. The effective ratio was 73. 68% (14/19). There was no statistical significance in the effective ratio between the two groups ( x2 = 0. 03, P > 0. 05). However, the Azithromycin group was superior to the control group both in the one week cure rate (t = 7.50,P< 0.05) and on defervescence time (t = 34. 05, P < 0. 05 ) and rales disappearance (t = 2. 39, P < 0. 05 ). Conclusion Azithromycin injection is more effective than domestic Azithromycin in the treatment of mycoplasma pneumoniae pneumonia,especially in the aspect of improving symptoms.
